Technology developed at HIRI records ribonucleic acids in individual living cells.
Do we simply ingest a diagnostic probiotic based on programmed ribonucleic acids to analyze the intestinal health from individual cells in the future? Researchers at the Helmholtz Institute for RNA-based Infection Research (HIRI) and the Julius-Maximilians-Universität (JMU) in Würzburg have developed a new technology they call TIGER. It allows complex processes in individual cells to be deciphered in vivo by recording past RNA transcripts. The findings were published in the journal Nature Biotechnology on 5 January 2023.
Bacterial and viral infections can cause severe acute symptoms, but they can also have devastating long-term consequences such as triggering cancer. Consequently, scientists are looking for new approaches and technologies to better understand the course of diseases and predict the development of cells and tissues. They use increasingly precise methods to analyze the underlying processes in individual cells. One goal is to detect changes in gene activity, which in turn may indicate a pathological event.
Ribonucleic acids (RNAs) make an important contribution to this understanding. They can provide evidence of genetic activity as only active genes produce RNA copies (transcripts) in a process called transcription. However, RNA molecules expressed in transcription represent a current state only. Linking past cell events—for example, a bacterial infection—to present conditions and deducing future outcomes proves challenging.
"The identity and behavior of a cell not only depends on its current intracellular make-up and extracellular environment but also on its past states. We were looking for an efficient procedure at the single-cell level to peer into the past and connect it to the present,” Prof Chase Beisel explains. The head of the RNA Synthetic Biology Department at the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg is the lead author of the study, which has been published in the journal Nature Biotechnology. The institute is a site of the Braunschweig Helmholtz Centre for Infection Research (HZI) in cooperation with the Julius-Maximilians-Universität (JMU) of Würzburg, where Beisel also holds a professorship.
Peering into the cellular past
In their publication, the authors present a new technological approach that could significantly advance medical diagnostics in the future. Called TIGER, their method is a way to record the presence of specific RNAs in individual living cells.
"Through RNA recording, TIGER connects current cellular states with past transcriptional states," says first author Chunlei Jiao. TIGER can quantify relative gene expression, detect differences between individual nucleotides, record multiple transcripts simultaneously and read out single-cell phenomena.
According to Jiao, there are striking advantages to the method: "Previous research has only been able to approximate past cell states using huge amounts of data and computational prediction tools to measure asynchronous cells over time." The scientists involved in the study were able to record the transfer of antibiotic resistance between Escherichia coli cells as well as the invasion of host cells by Salmonella.
In the future, TIGER could be used to look into the transcription history of individual cells in a living organism and link it to the current status quo in order to decipher complex cellular reactions—in vivo and non-invasively. For example, one could imagine ingesting a TIGER probiotic to have the state of the digestive tract recorded and analyzed later on, the authors conclude.
TIGER (an acronym of "Transcribed RNAs Inferred by Genetically Encoded Records") uses reprogrammed tracrRNAs (Rptrs) to record selected cellular transcripts as stored DNA edits in individual living bacterial cells. Rptrs are designed to base pair with recognized transcripts and convert them into guide RNAs. The guide RNAs then instruct a Cas9 base editor to target an introduced DNA target. The extent of base editing can then be read by sequencing. The technology takes advantage of findings that led to the development of LEOPARD, an in vitro diagnostic platform, in a previous study (Jiao C, Sharma S, Dugar G et al, Non-canonical crRNAs derived from host transcripts enable multiplexable RNA detection by Cas9, Science 2021).
The study was supported by several grants from the German Research Foundation (DFG) including through SPP 2141, funding from the European Research Council (ERC Consolidator Award to Chase Beisel) and the Gottfried Wilhelm Leibniz Award to Jörg Vogel, as well as by the Centre for Microbial Single-cell Sequencing (MICROSEQ).
This press release is also available on our website: https://www.helmholtz-hzi.de/en/news-events/news/view/article/complete/mit-tiger...
Helmholtz Institute for RNA-based Infection Research:
The Helmholtz Institute for RNA-based Infection Research (HIRI) is the first institution of its kind worldwide to combine ribonucleic acid (RNA) research with infection biology. Based on novel findings from its strong basic research program, the institute’s long-term goal is to develop innovative therapeutic approaches to better diagnose and treat human infections.
HIRI is a site of the Braunschweig Helmholtz Centre for Infection Research (HZI) in cooperation with the Julius-Maximilians-Universität Würzburg (JMU) and is located on the Würzburg Medical Campus. More information at http://www.helmholtz-hiri.de
Helmholtz Centre for Infection Research:
Scientists at the Helmholtz Centre for Infection Research (HZI) in Braunschweig and its other sites in Germany are engaged in the study of bacterial and viral infections and the body’s defence mechanisms. They have a profound expertise in natural compound research and its exploitation as a valuable source for novel anti-infectives. As member of the Helmholtz Association and the German Center for Infection Research (DZIF), the HZI performs translational research laying the ground for the development of new treatments and vaccines against infectious diseases. http://www.helmholtz-hzi.de/en
Dr Britta Grigull
Head of Communications
Helmholtz Institute for RNA-based Infection Research (HIRI)
Josef-Schneider-Str. 2 / D15
+49 931 31 81801
Jiao C, Reckstadt C, König F, Homberger C, Yu J, Vogel J, Westermann AJ, Sharma CM, Beisel CL (2023) RNA recording in single bacterial cells using reprogrammed tracrRNAs
Nature Biotechnology, DOI: 10.1038/s41587-022-01604-8
Merkmale dieser Pressemitteilung:
Journalisten, Wirtschaftsvertreter, Wissenschaftler
Biologie, Chemie, Medizin
Sie können Suchbegriffe mit und, oder und / oder nicht verknüpfen, z. B. Philo nicht logie.
Verknüpfungen können Sie mit Klammern voneinander trennen, z. B. (Philo nicht logie) oder (Psycho und logie).
Zusammenhängende Worte werden als Wortgruppe gesucht, wenn Sie sie in Anführungsstriche setzen, z. B. „Bundesrepublik Deutschland“.
Die Erweiterte Suche können Sie auch nutzen, ohne Suchbegriffe einzugeben. Sie orientiert sich dann an den Kriterien, die Sie ausgewählt haben (z. B. nach dem Land oder dem Sachgebiet).
Haben Sie in einer Kategorie kein Kriterium ausgewählt, wird die gesamte Kategorie durchsucht (z.B. alle Sachgebiete oder alle Länder).